|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3500564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17761332.0 |
| Date of filing the European patent application | 2017-08-09 | |
| (97) | Date of publication of the European application | 2019-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (86) | Number | PCT/IB2017/054862 |
| Date | 2017-08-09 |
| (87) | Number | WO 2018/033832 |
| Date | 2018-02-22 |
| (30) | Number | Date | Country code |
| 201662377137 P | 2016-08-19 | US |
| (72) |
BOEHM, Markus, US
CABRAL, Shawn, US
DOWLING, Matthew S., US
FUTATSUGI, Kentaro, US
HUARD, Kim, US
LEE, Esther Cheng Yin, US
LI, Qifang, US
LONDREGAN, Allyn T., US
POLIVKOVA, Jana, US
PRICE, David A., US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Diacilglicerolio aciltransferazės 2 inhibitoriai |
| DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-12-22 | 9 | 312.00 EUR |
| 2026-08-09 |